Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
234.16
-0.04 (-0.02%)
May 27, 2026, 12:50 PM EDT - Market open
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, Axsome Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $270.28. The average 1-year stock price forecast is 15.43% higher than the current stock price, while the lowest is $200 (-14.59%) and the highest is $328.81 (+40.42%).
Price Target: $270.28 (+15.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 17 | 17 | 17 | 17 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $258 | Buy | Reiterates | $258 | +10.18% | May 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $228 → $310 | Buy | Reiterates | $228 → $310 | +32.39% | May 8, 2026 |
| Needham | Needham | Buy Reiterates $267 | Buy | Reiterates | $267 | +14.02% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $242 → $302 | Buy | Maintains | $242 → $302 | +28.97% | May 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $225 → $255 | Buy | Reiterates | $225 → $255 | +8.90% | May 5, 2026 |
Financial Forecast
Revenue This Year
994.85M
from 638.50M
Increased by 55.81%
Revenue Next Year
1.64B
from 994.85M
Increased by 65.05%
EPS This Year
-1.56
from -3.68
EPS Next Year
6.69
from -1.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.2B | 2.1B | ||||||
| Avg | 994.9M | 1.6B | ||||||
| Low | 850.2M | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 80.1% | 112.2% | ||||||
| Avg | 55.8% | 65.1% | ||||||
| Low | 33.2% | 37.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.07 | 14.44 | ||||||
| Avg | -1.56 | 6.69 | ||||||
| Low | -2.70 | 1.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.